Renal disease pathophysiology and treatment: contributions from the rat

The rat has classically been the species of choice for pharmacological studies and disease modeling, providing a source of high-quality physiological data on cardiovascular and renal pathophysiology over many decades. Recent developments in genome engineering now allow us to capitalize on the wealth...

Full description

Bibliographic Details
Main Authors: Linda J. Mullins, Bryan R. Conway, Robert I. Menzies, Laura Denby, John J. Mullins
Format: Article
Language:English
Published: The Company of Biologists 2016-12-01
Series:Disease Models & Mechanisms
Subjects:
Online Access:http://dmm.biologists.org/content/9/12/1419
_version_ 1828304339832143872
author Linda J. Mullins
Bryan R. Conway
Robert I. Menzies
Laura Denby
John J. Mullins
author_facet Linda J. Mullins
Bryan R. Conway
Robert I. Menzies
Laura Denby
John J. Mullins
author_sort Linda J. Mullins
collection DOAJ
description The rat has classically been the species of choice for pharmacological studies and disease modeling, providing a source of high-quality physiological data on cardiovascular and renal pathophysiology over many decades. Recent developments in genome engineering now allow us to capitalize on the wealth of knowledge acquired over the last century. Here, we review rat models of hypertension, diabetic nephropathy, and acute and chronic kidney disease. These models have made important contributions to our understanding of renal diseases and have revealed key genes, such as Ace and P2rx7, involved in renal pathogenic processes. By targeting these genes of interest, researchers are gaining a better understanding of the etiology of renal pathologies, with the promised potential of slowing disease progression or even reversing the damage caused. Some, but not all, of these target genes have proved to be of clinical relevance. However, it is now possible to generate more sophisticated and appropriate disease models in the rat, which can recapitulate key aspects of human renal pathology. These advances will ultimately be used to identify new treatments and therapeutic targets of much greater clinical relevance.
first_indexed 2024-04-13T14:09:38Z
format Article
id doaj.art-5e2b82ec40dd485d849c393926b5e345
institution Directory Open Access Journal
issn 1754-8403
1754-8411
language English
last_indexed 2024-04-13T14:09:38Z
publishDate 2016-12-01
publisher The Company of Biologists
record_format Article
series Disease Models & Mechanisms
spelling doaj.art-5e2b82ec40dd485d849c393926b5e3452022-12-22T02:43:49ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112016-12-019121419143310.1242/dmm.027276027276Renal disease pathophysiology and treatment: contributions from the ratLinda J. Mullins0Bryan R. Conway1Robert I. Menzies2Laura Denby3John J. Mullins4 University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK The rat has classically been the species of choice for pharmacological studies and disease modeling, providing a source of high-quality physiological data on cardiovascular and renal pathophysiology over many decades. Recent developments in genome engineering now allow us to capitalize on the wealth of knowledge acquired over the last century. Here, we review rat models of hypertension, diabetic nephropathy, and acute and chronic kidney disease. These models have made important contributions to our understanding of renal diseases and have revealed key genes, such as Ace and P2rx7, involved in renal pathogenic processes. By targeting these genes of interest, researchers are gaining a better understanding of the etiology of renal pathologies, with the promised potential of slowing disease progression or even reversing the damage caused. Some, but not all, of these target genes have proved to be of clinical relevance. However, it is now possible to generate more sophisticated and appropriate disease models in the rat, which can recapitulate key aspects of human renal pathology. These advances will ultimately be used to identify new treatments and therapeutic targets of much greater clinical relevance.http://dmm.biologists.org/content/9/12/1419RatChronic kidney diseaseDiabetic nephropathyGenetically modified ratsEnd-organ damageRenal transplantation
spellingShingle Linda J. Mullins
Bryan R. Conway
Robert I. Menzies
Laura Denby
John J. Mullins
Renal disease pathophysiology and treatment: contributions from the rat
Disease Models & Mechanisms
Rat
Chronic kidney disease
Diabetic nephropathy
Genetically modified rats
End-organ damage
Renal transplantation
title Renal disease pathophysiology and treatment: contributions from the rat
title_full Renal disease pathophysiology and treatment: contributions from the rat
title_fullStr Renal disease pathophysiology and treatment: contributions from the rat
title_full_unstemmed Renal disease pathophysiology and treatment: contributions from the rat
title_short Renal disease pathophysiology and treatment: contributions from the rat
title_sort renal disease pathophysiology and treatment contributions from the rat
topic Rat
Chronic kidney disease
Diabetic nephropathy
Genetically modified rats
End-organ damage
Renal transplantation
url http://dmm.biologists.org/content/9/12/1419
work_keys_str_mv AT lindajmullins renaldiseasepathophysiologyandtreatmentcontributionsfromtherat
AT bryanrconway renaldiseasepathophysiologyandtreatmentcontributionsfromtherat
AT robertimenzies renaldiseasepathophysiologyandtreatmentcontributionsfromtherat
AT lauradenby renaldiseasepathophysiologyandtreatmentcontributionsfromtherat
AT johnjmullins renaldiseasepathophysiologyandtreatmentcontributionsfromtherat